241 related articles for article (PubMed ID: 26222774)
1. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women.
Lewis JR; Lim WH; Ueland T; Wong G; Zhu K; Lim EM; Bollerslev J; Prince RL
PLoS One; 2015; 10(7):e0134266. PubMed ID: 26222774
[TBL] [Abstract][Full Text] [Related]
2. Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study.
Lewis JR; Lim WH; Zhu K; Wong G; Dhaliwal SS; Lim EM; Ueland T; Bollerslev J; Prince RL
Am J Nephrol; 2014; 39(1):66-74. PubMed ID: 24457210
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5.
Marques GL; Hayashi S; Bjällmark A; Larsson M; Riella M; Olandoski M; Lindholm B; Nascimento MM
Sci Rep; 2021 Jan; 11(1):2473. PubMed ID: 33510348
[TBL] [Abstract][Full Text] [Related]
4. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin and osteoprotegerin/TRAIL ratio are associated with cardiovascular dysfunction and mortality among patients with renal failure.
Kuźniewski M; Fedak D; Dumnicka P; Stępień E; Kuśnierz-Cabala B; Cwynar M; Sułowicz W
Adv Med Sci; 2016 Sep; 61(2):269-275. PubMed ID: 27128817
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up.
Nagai K; Sairenchi T; Irie F; Watanabe H; Ota H; Yamagata K
PLoS One; 2016; 11(6):e0156792. PubMed ID: 27272675
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
[TBL] [Abstract][Full Text] [Related]
9. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
Winther S; Christensen JH; Flyvbjerg A; Schmidt EB; Jørgensen KA; Skou-Jørgensen H; Svensson M
Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.
Yilmaz MI; Siriopol D; Saglam M; Unal HU; Karaman M; Gezer M; Kilinc A; Eyileten T; Guler AK; Aydin İ; Vural A; Oguz Y; Covic A; Ortiz A; Kanbay M
Calcif Tissue Int; 2016 Aug; 99(2):121-30. PubMed ID: 27016924
[TBL] [Abstract][Full Text] [Related]
12. Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study.
Mok Y; Matsushita K; Sang Y; Ballew SH; Grams M; Shin SY; Jee SH; Coresh J
PLoS One; 2016; 11(4):e0153429. PubMed ID: 27092943
[TBL] [Abstract][Full Text] [Related]
13. Rate of change in renal function and mortality in elderly treated hypertensive patients.
Chowdhury EK; Langham RG; Ademi Z; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1154-61. PubMed ID: 25901093
[TBL] [Abstract][Full Text] [Related]
14. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
[TBL] [Abstract][Full Text] [Related]
15. Five-year decline in estimated glomerular filtration rate associated with a higher risk of renal disease and atherosclerotic vascular disease clinical events in elderly women.
Lim WH; Lewis JR; Wong G; Dogra GK; Zhu K; Lim EM; Dhaliwal SS; Prince RL
QJM; 2013 May; 106(5):443-50. PubMed ID: 23407347
[TBL] [Abstract][Full Text] [Related]
16. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.
Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM;
Atherosclerosis; 2018 Mar; 270():13-20. PubMed ID: 29407881
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
19. Periodontal Disease and Risks of Kidney Function Decline and Mortality in Older People: A Community-Based Cohort Study.
Chen YT; Shih CJ; Ou SM; Hung SC; Lin CH; Tarng DC;
Am J Kidney Dis; 2015 Aug; 66(2):223-30. PubMed ID: 25747403
[TBL] [Abstract][Full Text] [Related]
20. Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function.
Collado S; Coll E; Nicolau C; Azqueta M; Pons M; Cruzado JM; de la Torre B; Deulofeu R; Mojal S; Pascual J; Cases A
BMC Nephrol; 2017 Sep; 18(1):290. PubMed ID: 28882110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]